Evidence map›Paper›PMID 26134573›Full record

ArticleThe Journal of biological chemistry2015

Reduced Nuclease Activity of Apurinic/Apyrimidinic Endonuclease (APE1) Variants on Nucleosomes: IDENTIFICATION OF ACCESS RESIDUES.

John M Hinz, Peng Mao, Daniel R McNeill, David M Wilson

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 40 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Generation of Recombinant Nucleosomes Containing Site-Specific DNA Damage.Methods in molecular biology (Clifton, N.J.) · 2023
    Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

John M HinzSchool of Molecular Biosciences, Washington State University, Pullman, Washington 99164-7520 and. Electronic address: jmhinz@wsu.edu.
Peng MaoSchool of Molecular Biosciences, Washington State University, Pullman, Washington 99164-7520 and.
Daniel R McNeillLaboratory of Molecular Gerontology, National Institute on Aging, IRP, National Institutes of Health, Baltimore, Maryland 21224.
David M WilsonLaboratory of Molecular Gerontology, National Institute on Aging, IRP, National Institutes of Health, Baltimore, Maryland 21224.
Washington State University · USNational Institute on Aging · USNational Institutes of Health · US

Funding

Base Excision DNA Repair in Disease Susceptibility and TreatmentZIAAG000750 · NIA · NATIONAL INSTITUTE ON AGING · PI BOHR, VILHELM A · 2009 to 2019
$5.4M
DNA REPAIR IN A HORMONE-RESPONSIVE GENER01ES004106 · NIEHS · WASHINGTON STATE UNIVERSITY · PI SMERDON, MICHAEL J · 1986 to 2014
$4.5M
Repair of Carcinogen Damaged DNA in Human ChromatinR37ES002614 · NIEHS · WASHINGTON STATE UNIVERSITY · PI SMERDON, MICHAEL J · 2001 to 2010
$4.0M
Repair Mechanisms For Oxidative DNA DamageZIAAG000743 · NIA · NATIONAL INSTITUTE ON AGING · PI WILSON, DAVID · 2009 to 2015
$2.5M
REPAIR OF CARCINOGEN-DAMAGED DNA IN HUMAN CHROMATINR01ES002614 · NIEHS · WASHINGTON STATE UNIVERSITY · PI SMERDON, MICHAEL J, WYRICK, JOHN J · 1985 to 2015
$2.5M
Determination of histone modifications necessary for DNA base excision repair inR21ES020955 · NIEHS · WASHINGTON STATE UNIVERSITY · PI HINZ, JOHN MICHAEL · 2012 to 2013
$403k
Intramural NIH HHSNIEHS NIH HHS ES002614NIEHS NIH HHS ES004106NIEHS NIH HHS ES020955NIEHS NIH HHS R01 ES002614NIEHS NIH HHS R01 ES004106NIEHS NIH HHS R21 ES020955NIEHS NIH HHS R37 ES002614
6 · The paper itself

Abstract

Non-coding apurinic/apyrimidinic (AP) sites are generated at high frequency in genomic DNA via spontaneous hydrolytic, damage-induced or enzyme-mediated base release. AP endonuclease 1 (APE1) is the predominant mammalian enzyme responsible for initiating removal of mutagenic and cytotoxic abasic lesions as part of the base excision repair (BER) pathway. We have examined here the ability of wild-type (WT) and a collection of variant/mutant APE1 proteins to cleave at an AP site within a nucleosome core particle. Our studies indicate that, in comparison to the WT protein and other variant/mutant enzymes, the incision activity of the tumor-associated variant R237C and the rare population variant G241R are uniquely hypersensitive to nucleosome complexes in the vicinity of the AP site. This defect appears to stem from an abnormal interaction of R237C and G241R with abasic DNA substrates, but is not simply due to a DNA binding defect, as the site-specific APE1 mutant Y128A, which displays markedly reduced AP-DNA complex stability, did not exhibit a similar hypersensitivity to nucleosome structures. Notably, this incision defect of R237C and G241R was observed on a pre-assembled DNA glycosylase·AP-DNA complex as well. Our results suggest that the BER enzyme, APE1, has acquired distinct surface residues that permit efficient processing of AP sites within the context of protein-DNA complexes independent of classic chromatin remodeling mechanisms.

Indexed as

DNADNA-(Apurinic or Apyrimidinic Site) LyaseDNA DamageDNA RepairEscherichia coliGene ExpressionHumansIsoenzymesModels, MolecularMutationNucleosomesProtein Interaction Domains and MotifsRecombinant ProteinsAPEX1 protein, humanDNADNA-(Apurinic or Apyrimidinic Site) LyaseIsoenzymesNucleosomesRecombinant ProteinsAP endonuclease 1base excision repair (BER)DNA damagegenetic polymorphismnucleosomeprotein-DNA interaction

Identifiers

PMID26134573
PMCPMC4543664
OpenAlexW1862617947

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.